Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Cisplatin in Locally Advanced HNSCC
NCT04780750Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Apr 2021
- Primary completion
- Apr 2022
01
Overview
A Phase 3 trial of docetaxel in head and neck squamous cell carcinoma (HNSCC), sponsored by Assiut University. Status: unknown.
02
Drugs
docetaxel
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT04780750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04780750.